DE69535316D1 - Als lerk6 bezeichnetes cytokin - Google Patents

Als lerk6 bezeichnetes cytokin

Info

Publication number
DE69535316D1
DE69535316D1 DE69535316T DE69535316T DE69535316D1 DE 69535316 D1 DE69535316 D1 DE 69535316D1 DE 69535316 T DE69535316 T DE 69535316T DE 69535316 T DE69535316 T DE 69535316T DE 69535316 D1 DE69535316 D1 DE 69535316D1
Authority
DE
Germany
Prior art keywords
lerk6
cytokin
designated
lerk
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69535316T
Other languages
English (en)
Other versions
DE69535316T2 (de
Inventor
P Cerretti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of DE69535316D1 publication Critical patent/DE69535316D1/de
Application granted granted Critical
Publication of DE69535316T2 publication Critical patent/DE69535316T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00153—Wound bandages coloured or with decoration pattern or printing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69535316T 1994-10-05 1995-10-04 Als lerk6 bezeichnetes cytokin Expired - Fee Related DE69535316T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US31839394A 1994-10-05 1994-10-05
US318393 1994-10-05
US53870995A 1995-10-03 1995-10-03
US538709 1995-10-03
PCT/US1995/012779 WO1996010911A1 (en) 1994-10-05 1995-10-04 Cytokine designated lerk-6

Publications (2)

Publication Number Publication Date
DE69535316D1 true DE69535316D1 (de) 2007-01-11
DE69535316T2 DE69535316T2 (de) 2007-05-31

Family

ID=26981457

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69535316T Expired - Fee Related DE69535316T2 (de) 1994-10-05 1995-10-04 Als lerk6 bezeichnetes cytokin

Country Status (14)

Country Link
US (1) US6268482B1 (de)
EP (1) EP0785716B1 (de)
JP (1) JP2002504801A (de)
KR (1) KR970705923A (de)
AT (1) ATE346498T1 (de)
DE (1) DE69535316T2 (de)
DK (1) DK0785716T3 (de)
ES (1) ES2277335T3 (de)
FI (1) FI971276A (de)
MX (1) MX9702341A (de)
NO (1) NO971378L (de)
NZ (1) NZ295022A (de)
PT (1) PT785716E (de)
WO (1) WO1996010911A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268476B1 (en) * 1994-09-19 2001-07-31 President And Fellows Of Harvard College EPH receptor ligands, and uses related thereto
US5919905A (en) * 1994-10-05 1999-07-06 Immunex Corporation Cytokine designated LERK-6
USRE37582E1 (en) 1994-10-05 2002-03-12 Immunex Corporation Cytokine designated LERK-6
DE69535316T2 (de) 1994-10-05 2007-05-31 Immunex Corp., Seattle Als lerk6 bezeichnetes cytokin
EP0842272A4 (de) * 1995-07-20 2002-03-06 Amrad Operations Pty Ltd Neuartige rezeptorliganden und genetische sequenzen, welche für diese kodieren
IL125919A0 (en) * 1996-03-21 1999-04-11 Immunex Corp Cytokine designated lerk-8
US8461119B2 (en) 2002-09-24 2013-06-11 The Burnham Institute Agents that modulate Eph receptor activity
NO325620B1 (no) * 2003-10-21 2008-06-30 Revolt Technology Ltd Elektrode, fremgangsmate for fremstilling derav, metall/luft-brenselcelle og metallhydrid-battericelle
KR20070118230A (ko) 2005-01-27 2007-12-14 더 번햄 인스티튜트 Ｅｐｈｂ 수용체-결합 펩티드
CN112481367A (zh) * 2008-03-31 2021-03-12 健泰科生物技术公司 用于治疗和诊断哮喘的组合物和方法
KR101615474B1 (ko) 2010-12-16 2016-04-25 제넨테크, 인크. Th2 억제에 관한 진단 및 치료

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994011384A1 (en) 1992-11-13 1994-05-26 Immunex Corporation Novel cytokine designated elk ligand
US5516658A (en) 1993-08-20 1996-05-14 Immunex Corporation DNA encoding cytokines that bind the cell surface receptor hek
US5457048A (en) * 1993-12-03 1995-10-10 La Jolla Cancer Research Foundation Eph-related tyrosine kinases, nucleotide sequences and methods of use
US5795734A (en) * 1994-09-19 1998-08-18 President And Fellows Of Harvard College EPH receptor ligands, and uses related thereto
DE69535316T2 (de) 1994-10-05 2007-05-31 Immunex Corp., Seattle Als lerk6 bezeichnetes cytokin
JPH10512440A (ja) * 1994-12-06 1998-12-02 イミュネックス・コーポレーション サイトカイン”ｌｅｒｋ−７”
US6057124A (en) 1995-01-27 2000-05-02 Amgen Inc. Nucleic acids encoding ligands for HEK4 receptors

Also Published As

Publication number Publication date
KR970705923A (ko) 1997-11-03
EP0785716A4 (de) 1999-08-25
AU687647B2 (en) 1998-02-26
FI971276A0 (fi) 1997-03-26
NO971378D0 (no) 1997-03-24
ATE346498T1 (de) 2006-12-15
EP0785716A1 (de) 1997-07-30
JP2002504801A (ja) 2002-02-12
EP0785716B1 (de) 2006-11-29
NO971378L (no) 1997-06-05
DK0785716T3 (da) 2007-04-02
ES2277335T3 (es) 2007-07-01
US6268482B1 (en) 2001-07-31
MX9702341A (es) 1997-06-28
FI971276A (fi) 1997-05-27
WO1996010911A1 (en) 1996-04-18
DE69535316T2 (de) 2007-05-31
AU3826895A (en) 1996-05-02
NZ295022A (en) 1999-04-29
PT785716E (pt) 2007-02-28

Similar Documents

Publication Publication Date Title
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
DE69939982D1 (de) B7l-1 moleküle
ES2143620T3 (es) Polipeptidos modificados con actividad biologica incrementada.
IL140937A0 (en) Molecules designated ldcam
DE69534235D1 (de) Cytokin lerk-7
DE69014440T2 (de) Sprachcodierungs-/-decodierungssystem.
ES2120052T3 (es) Receptor de prostaglandina fp y dna que lo codifica.
DE3785164T2 (de) Alkalische cellulase kodierende dns-fragmente und diese enthaltende plasmide.
DE69535316D1 (de) Als lerk6 bezeichnetes cytokin
DE68912685D1 (de) Reinigung von Glucosaminoglucan abbauenden Enzymen.
DE69405230T2 (de) Prostaglandinrezeptor ep1 kodierende dna
DE68910676D1 (de) Verwendung von Creosot als antispastischer Wirkstoff.
AU3118095A (en) Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme
DE3877941T2 (de) Membrantastatur.
ES2187939T3 (es) Moleculas aisladas de acido nucleico codificantes de miembros de la familia ssx y utilizaciones de las mismas.
DE68923549D1 (de) Dekodierringanordnung.
TR26073A (tr) Bacillus thuringiensis jenleri,toksinleri ve insektisid olarak kullanimlari.
PT870015E (pt) Novas xilanases os genes que as codificam e as suas utilizacoes
DK1007647T3 (da) Höjniveauekspression af INGAP
DE69939587D1 (en) Semaphorin polypeptide
DE69003306T2 (de) Reinigung von Proteinhydrolysaten.
IT8422824A0 (it) Fibra luminescente.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee